Home > Insider Trading > Filing (0001787306-24-000133)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1787306	Arcutis Biotherapeutics Inc.	ARQT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1740378	Joseph David Topper	3027 Townsgate Road, Suite 300 Westlake Village CA 91361	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-09-21	60,000	$0.00	170,000	No	4	A	Direct
Common Stock	Disposition	2024-09-24	11,626	$9.48	158,374	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Footnotes

Represents Performance Stock Units ("PSUs"), initially granted on June 20, 2024, in which the shares were subject to a performance-based vesting condition, which was deemed satisfied on September 21, 2024 (the "Vesting Commencement Date"). Therefore, 50% of the shares vested on September 21, 2024 and the remaining 50% of the shares vest on September 21, 2025, subject to the Reporting Person's continued service with the Company through the applicable vesting date.
Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the PSUs, the shares were sold upon the vesting of the PSUs solely to cover applicable tax withholding.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.40 to $9.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.